come up with 1 topics on a current literature review of the drug Glatiramer(copaxone)
And provide 6 primary literature references for each topic
Glitrimar Asset
Glitrimar Acetate (also known as Copilimer 1, Sip-1, or Copxon) is currently an anemomomeduer drug that is used to treat multiple sclerosis. Glatiramer acetate is allowed to reduce the frequency of relapses in the United States, but does not reduce the inability to develop.A 2010 Cochrane Review concludes that there was partial effect on the "Repeat Clinical Results" in Glitterarum Asset but there was no effect of this disease outbreak. [3] As a result, it is approved by the FDA to reduce the frequency of rehabilitation, but not for the reduction of disability.
Get Answers For Free
Most questions answered within 1 hours.